Telpharm Limited

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—6

Registered number: 10988023

		2025		2024
	Notes	£	£	£	£
FIXED ASSETS
Intangible Assets	4		861,250		927,500
Tangible Assets	5		30,967		25,090

			892,217		952,590
CURRENT ASSETS
Stocks	6	42,190		54,248
Debtors	7	281,471		262,901
Cash at bank and in hand		94,228		75,409

		417,889		392,558
Creditors: Amounts Falling Due Within One Year	8	(1,132,173 )		(1,117,794 )

NET CURRENT ASSETS (LIABILITIES)			(714,284 )		(725,236 )

TOTAL ASSETS LESS CURRENT LIABILITIES			177,933		227,354

Creditors: Amounts Falling Due After More Than One Year	9		(144,308 )		(116,912 )

NET ASSETS			33,625		110,442

CAPITAL AND RESERVES
Called up share capital	10		400		400
Profit and Loss Account			33,225		110,042

SHAREHOLDERS' FUNDS			33,625		110,442

Page 1

Page 2

Telpharm Limited

Balance Sheet (continued)

As At 30 September 2025

For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr Sarwan Samrai

Director

07/05/2026

The notes on pages 3 to 6 form part of these financial statements.

1. General Information

Telpharm Limited is a private company, limited by shares, incorporated in England & Wales, registered number 10988023 . The registered office is 2 Upper Russell Street, Wednesbury, West Midlands, WS10 7AR.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Sale of goods

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.

Rendering of services

Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

2.3. Intangible Fixed Assets and Amortisation - Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2018, is being amortised evenly over its estimated useful life of twenty years.

2.4. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery	15% on reducing balance
Fixtures & Fittings	15% on reducing balance

2.5. Stocks and Work in Progress

Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.

Page 3

Page 4

Telpharm Limited

Notes to the Financial Statements (continued)

For The Year Ended 30 September 2025

2.6. Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.

Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 13 (2024: 13)

4. Intangible Assets

	Goodwill
	£
Cost
As at 1 October 2024	1,325,000

As at 30 September 2025	1,325,000

Amortisation
As at 1 October 2024	397,500
Provided during the period	66,250

As at 30 September 2025	463,750

Net Book Value
As at 30 September 2025	861,250

As at 1 October 2024	927,500

Page 4

Page 5

Telpharm Limited

Notes to the Financial Statements (continued)

For The Year Ended 30 September 2025

5. Tangible Assets

	Plant & Machinery	Fixtures & Fittings	Total
	£	£	£
Cost
As at 1 October 2024	18,613	19,336	37,949
Additions	1,208	8,620	9,828

As at 30 September 2025	19,821	27,956	47,777

Depreciation
As at 1 October 2024	6,322	6,537	12,859
Provided during the period	2,000	1,951	3,951

As at 30 September 2025	8,322	8,488	16,810

Net Book Value
As at 30 September 2025	11,499	19,468	30,967

As at 1 October 2024	12,291	12,799	25,090

6. Stocks

	2025	2024
	£	£
Finished goods	42,190	54,248

7. Debtors

	2025	2024
	£	£
Due within one year
Trade debtors	120,633	121,251
Other debtors	160,838	141,650

	281,471	262,901

8. Creditors: Amounts Falling Due Within One Year

	2025	2024
	£	£
Trade creditors	219,341	162,090
Bank loans and overdrafts	35,449	21,840
Other creditors	820,320	867,737
Taxation and social security	57,063	66,127

	1,132,173	1,117,794

Page 5

Page 6

Telpharm Limited

Notes to the Financial Statements (continued)

For The Year Ended 30 September 2025

9. Creditors: Amounts Falling Due After More Than One Year

	2025	2024
	£	£
Bank loans	144,308	116,912

10. Share Capital

	2025	2024
Allotted, called up and fully paid	£	£
100 Ordinary Shares of £ 1.00 each	100	100
90 Ordinary A shares of £ 1.00 each	90	90
90 Ordinary B shares of £ 1.00 each	90	90
100 Ordinary C shares of £ 1.00 each	100	100
20 Ordinary D shares of £ 1.00 each	20	20

	400	400

11. Related Party Transactions

Included in other debtors are the balances due from the companies mentioned below as at 30 September 2025:

- Samrai Properties Limited - £121,969 (2024 - 121,969)

- Samrai Hospitality Limited - £13,500 (2024 - £1,297)

Included in other creditors is the balance due to the company mentioned below as at 30 September 2025:

- Jubilee Pharmacy Limited - £790,901 (2024 - £795,675)

The all above loans are interest free and repayable on demand.

Sanjeev S Samrai, Sarwan D Samrai, Shindo K Samrai and Sharmila Samrai-Mahay are also directors in above companies mentioned as at 30 September 2025.

Page 6